FIELD: biotechnology. SUBSTANCE: concentration of native solution is carried out up to the kinematic viscosity coefficient 2-10 sSt following by its crystallization at temperature from -20 to +20 C, at pH 4.5-6.0 and separation of crystals of the first purine-containing product from the mother liquid by dehydration of mother liquid at 60-180 C up to the preparing of the second purine-containing product. EFFECT: improved method of purine products preparing. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
PROCESS FOR PRODUCING PURINE-CONTAINING COMPOUNDS | 0 |
|
SU675651A1 |
METHOD OF ISOLATING RIBOXINE | 0 |
|
SU744003A1 |
METHOD OF PREPARING OF AGENT FOR CARDIOVASCULAR DISEASE TREATMENT | 1990 |
|
SU1769428A1 |
MEDICINAL AGENT FOR CARDIOVASCULAR DISEASE TREATMENT AND METHOD OF ITS PREPARING | 1992 |
|
RU2063227C1 |
STRAIN STREPTOMYCES CHROMOFUSCUS AS PRODUCER OF BIOTIN-BINDING PROTEIN | 1990 |
|
RU2039822C1 |
METHOD OF PREPARING AMYLOLYTIC AND PROTEOLYTIC ENZYME COMPLEX | 1993 |
|
RU2054479C1 |
APPARATUS FOR SEPARATING MICROBIOLOGICAL SYNTHESIS PRODUCTS IN CRYSTALLINE STATE | 1990 |
|
SU1828661A3 |
PROCESS FOR PREPARING INOSINE | 1990 |
|
RU1755583C |
STABILIZED STREPTOKINASE POSSESSING THROMBOLYTIC ACTIVITY | 0 |
|
SU822551A1 |
METHOD OF PURIFYING ALPHA-AMYLASE | 0 |
|
SU696024A1 |
Authors
Dates
1995-01-27—Published
1991-06-28—Filed